Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 17/20 | 0.49 |
| ▸ | PLA2G7 | Q13093 | 5/20 | 0.48 |
| ▸ | ABHD6 | Q9BV23 | 5/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18064853 | 0.91 | MGLL (0.60) | MGLLPLA2G7ABHD6 | |
| SCHEMBL19628024 | 0.88 | MGLL (0.57) | MGLLPLA2G7ABHD6KDM4EALDH1A1 | |
| SCHEMBL19627999 | 0.87 | MGLL (0.52) | MGLLPLA2G7ABHD6KDM4EALDH1A1 | |
| SCHEMBL19627997 | 0.85 | MGLL (0.51) | MGLLPLA2G7ABHD6KDM4EALDH1A1 | |
| SCHEMBL19627996 | 0.85 | MGLL (0.58) | MGLLPLA2G7ABHD6KDM4EALDH1A1 | |
| SCHEMBL19628003 | 0.85 | MGLL (0.51) | MGLLPLA2G7ABHD6KDM4EALDH1A1 | |
| SCHEMBL19628011 | 0.80 | MGLL (0.48) | MGLLPLA2G7ABHD6 | |
| SCHEMBL19628015 | 0.80 | MGLL (0.48) | MGLLPLA2G7ABHD6 | |
| SCHEMBL18064859 | 0.78 | MGLL (0.71) | MGLLPLA2G7ABHD6 | |
| SCHEMBL19628004 | 0.78 | MGLL (0.45) | MGLLPLA2G7ABHD6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170334874-A1 | PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME | H. LUNDBECK A/S (DK) | 2017-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170334874-A1 | PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME | ABHD6, RABL6, ABHD16A | NPSR1 3866/4885MGLL 46/4885PLA2G7 204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.